The Galaxy Medicare IPO has become a hot topic among investors in the SME space. With steady fundamentals and growing interest in healthcare-related businesses, many are closely tracking the Galaxy Medicare IPO GMP (Grey Market Premium) to estimate potential listing gains. Let’s break down the IPO details, GMP updates, and expected returns.
Galaxy Medicare IPO Details
- IPO Type: Book Build Issue
- Issue Size: ₹22.31 Crores
- Fresh Issue: 0.33 crore shares (₹17.86 Crores)
- Offer for Sale (OFS): 0.08 crore shares (₹4.45 Crores)
- Price Band: ₹51 – ₹54 per share
- Lot Size: 2,000 shares
- Retail Investment (Min): ₹2,16,000 (4,000 shares at upper band)
- HNI Investment (Min): 3 lots (₹3,24,000)
Important Dates to Remember
- IPO Open Date: September 10, 2025
- IPO Close Date: September 12, 2025
- Allotment Date: September 15, 2025
- Listing Date (Tentative): September 17, 2025
- Exchange: NSE SME
Galaxy Medicare IPO GMP Today
As of September 11, 2025 (01:34 PM), the Galaxy Medicare IPO GMP is reported at ₹5. Based on the upper price band of ₹54, the estimated listing price is ₹59 per share.
This indicates a potential listing gain of 9.26% per share, which suggests moderate demand in the grey market.
While GMP is a useful indicator of listing expectations, investors should also evaluate fundamentals, financials, and sector outlook before making decisions.
What Does the GMP Indicate for Investors?
- A ₹5 GMP shows positive sentiment, though not very high compared to other SME IPOs.
- The expected listing gain of nearly 9% makes it appealing for short-term investors looking at listing day profits.
- Long-term investors may view Galaxy Medicare’s presence in the healthcare segment as a stable growth opportunity.
Should You Invest in Galaxy Medicare IPO?
- Pros: Healthcare sector growth, SME market exposure, positive GMP.
- Cons: High retail investment requirement (₹2.16 lakh minimum), relatively small GMP compared to other IPOs.
If you’re looking for moderate listing gains and exposure to the healthcare SME space, Galaxy Medicare IPO can be worth considering.
More IPO Insights from Finowings
Stay updated on the latest IPOs and GMP trends:
- Airfloa Rail Technology IPO
- Taurian MPS IPO
- Krupalu Metals IPO
For real-time Grey Market Premium updates, check our Live IPO GMP Tracker.
Conclusion
The Galaxy Medicare IPO GMP at ₹5 signals a steady but limited upside on listing. Investors should weigh their risk appetite before applying. With its healthcare positioning, the IPO offers both short-term listing opportunities and potential long-term value.
